Rigalleau, Vincent

Trial of Lixisenatide in Early Parkinson’s Disease

Meissner, W. G., Remy, P., Giordana, C., Maltête, D., Derkinderen, P., Houéto, J.-L., Anheim, M., Benatru, I., Boraud, T., Brefel-Courbon, C., et al. (2024) · New England Journal of Medicine

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 369

Occult Cushing’s syndrome in type-2 diabetes

Catargi, B., Rigalleau, V., Poussin, A., Ronci-Chaix, N., Bex, V., Vergnot, V., Gin, H., Roger, P., & Tabarin, A. (2003) · The Journal of Clinical Endocrinology & Metabolism

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 287

Low physical activity in patients with type 2 diabetes: The role of obesity

Fagour, C., Gonzalez, C., Pezzino, S., Florenty, S., Rosette-Narece, M., Gin, H., & Rigalleau, V. (2013) · Diabetes & Metabolism

Physical Activity and HealthDiabetes Management and Research

Cited by 70

Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort

Wargny, M., Croyal, M., Ragot, S., Gand, E., Jacobi, D., Trochu, J.-N., Prieur, X., Le May, C., Goronflot, T., Cariou, B., et al. (2022) · Cardiovascular Diabetology

Heart Failure Treatment and ManagementNutritional Studies and Diet

Cited by 21